ATE217307T1 - Heterocyclisch substituierte propensäure derivate als nmda antagonisten - Google Patents

Heterocyclisch substituierte propensäure derivate als nmda antagonisten

Info

Publication number
ATE217307T1
ATE217307T1 AT95933902T AT95933902T ATE217307T1 AT E217307 T1 ATE217307 T1 AT E217307T1 AT 95933902 T AT95933902 T AT 95933902T AT 95933902 T AT95933902 T AT 95933902T AT E217307 T1 ATE217307 T1 AT E217307T1
Authority
AT
Austria
Prior art keywords
acid derivatives
propeneic
nmda antagonists
heterocyclic substituted
heterocyclic
Prior art date
Application number
AT95933902T
Other languages
English (en)
Inventor
Boyd L Harrison
Philip L Nyce
Robert A Farr
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Application granted granted Critical
Publication of ATE217307T1 publication Critical patent/ATE217307T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pyrrole Compounds (AREA)
AT95933902T 1994-10-31 1995-09-21 Heterocyclisch substituierte propensäure derivate als nmda antagonisten ATE217307T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08332016 US5563157B1 (en) 1994-10-31 1994-10-31 Heterocycle substituted propenoic acid derivatives and pharmaceutical compositions thereof
PCT/US1995/012085 WO1996013501A1 (en) 1994-10-31 1995-09-21 Heterocycle substituted propenoic acid derivatives as nmda antagonists

Publications (1)

Publication Number Publication Date
ATE217307T1 true ATE217307T1 (de) 2002-05-15

Family

ID=23296353

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95933902T ATE217307T1 (de) 1994-10-31 1995-09-21 Heterocyclisch substituierte propensäure derivate als nmda antagonisten

Country Status (21)

Country Link
US (3) US5563157B1 (de)
EP (1) EP0790994B1 (de)
JP (1) JP3934678B2 (de)
KR (1) KR100401138B1 (de)
CN (1) CN1068001C (de)
AT (1) ATE217307T1 (de)
AU (1) AU696423B2 (de)
CA (1) CA2202992C (de)
DE (1) DE69526668T2 (de)
DK (1) DK0790994T3 (de)
ES (1) ES2173198T3 (de)
FI (1) FI971831A0 (de)
HU (1) HU222372B1 (de)
IL (1) IL115791A (de)
MX (1) MX9703146A (de)
NO (1) NO313197B1 (de)
NZ (1) NZ293842A (de)
PT (1) PT790994E (de)
TW (1) TW336232B (de)
WO (1) WO1996013501A1 (de)
ZA (1) ZA959046B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5922752A (en) * 1997-06-11 1999-07-13 Hoechst Marion Roussell, Inc. NMDA (n-methyl-d-aspartate) antagonists
GB9902455D0 (en) * 1999-02-05 1999-03-24 Zeneca Ltd Chemical compounds
IL154981A0 (en) 2000-10-10 2003-10-31 Smithkline Beecham Corp Substituted indoles, pharmaceutical compositions containing such indoles and their use as ppay-y-binding agents
JP2005506292A (ja) * 2001-03-08 2005-03-03 エモリー ユニバーシティ pHに依存するNMDAレセプターアンタゴニスト
KR20100045983A (ko) 2007-06-29 2010-05-04 에모리 유니버시티 신경보호를 위한 nmda 수용체 길항물질

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU216787B (hu) * 1990-07-16 1999-08-30 Merrell Dow Pharmaceuticals Inc. Eljárás excitátoros aminosav-antagonista hatású indolszármazékok és ezeket tartalmazó gyógyszerkészítmények előállítására
JP3094450B2 (ja) * 1990-10-15 2000-10-03 アストラゼネカ・アクチエボラーグ 神経保護特性を有するピペリジン誘導体
US5284862A (en) * 1991-03-18 1994-02-08 Warner-Lambert Company Derivatives of 2-carboxyindoles having pharmaceutical activity
GB9208492D0 (en) * 1992-04-16 1992-06-03 Glaxo Spa Heterocyclic compounds
US5519048A (en) * 1993-05-27 1996-05-21 Merrell Pharmaceuticals Inc. 3-(indol-3-yl)-propenoic acid derivatives and pharmaceutical compositions thereof
WO1994027964A1 (en) * 1993-05-27 1994-12-08 Merrell Dow Pharmaceuticals Inc. 3-(indol-3-yl) propenoic acid derivatives and as nmda antagonists

Also Published As

Publication number Publication date
TW336232B (en) 1998-07-11
EP0790994A1 (de) 1997-08-27
DE69526668D1 (de) 2002-06-13
ZA959046B (en) 1996-05-17
US5563157B1 (en) 1999-02-02
NO971991D0 (no) 1997-04-29
WO1996013501A1 (en) 1996-05-09
EP0790994B1 (de) 2002-05-08
HU222372B1 (hu) 2003-06-28
KR100401138B1 (ko) 2003-12-24
NO313197B1 (no) 2002-08-26
MX9703146A (es) 1997-06-28
PT790994E (pt) 2002-08-30
CA2202992A1 (en) 1996-05-09
ES2173198T3 (es) 2002-10-16
NO971991L (no) 1997-04-29
DE69526668T2 (de) 2003-01-02
CN1161696A (zh) 1997-10-08
NZ293842A (en) 1998-09-24
JP3934678B2 (ja) 2007-06-20
JPH10508019A (ja) 1998-08-04
FI971831L (fi) 1997-04-29
FI971831A7 (fi) 1997-04-29
CA2202992C (en) 2003-05-13
HUT77174A (hu) 1998-03-02
IL115791A (en) 2000-09-28
FI971831A0 (fi) 1997-04-29
US6180786B1 (en) 2001-01-30
CN1068001C (zh) 2001-07-04
US5981553A (en) 1999-11-09
AU3638795A (en) 1996-05-23
DK0790994T3 (da) 2002-08-26
AU696423B2 (en) 1998-09-10
IL115791A0 (en) 1996-01-19
US5563157A (en) 1996-10-08

Similar Documents

Publication Publication Date Title
EA200101177A1 (ru) Производные индола в качестве антагонистов прогестерона
DE69710319D1 (de) Para-substituierte phenylpropansäure derivate als integrin-antagonisten
EA200000920A1 (ru) Производные бициклических гидроксамовых кислот
FI980341A0 (fi) 2-oksi-indolijohdannaisia
DE69616480D1 (de) Piperidinderivate als neurokininantagonisten
ATE243697T1 (de) Substitutierte heterozyclische derivate als crf antagonisten
TR200101155T2 (tr) 4-Aroil Piperidin CCR-3 Reseptör Antagonistleri III
EA200201179A1 (ru) Производные 2-аминокарбонил-9h-пурина
DE69706407D1 (de) META-SUBSTITUIERTE PHENYLENDERIVATE UND IHRE VERWENDUNG ALS ALPHAvBETA3 INTERGRIN-ANTAGONISTEN ODER INHIBITOREN
CH1175401H1 (de) Piperazin Derivate verwendbar als CCR5 Antagonisten
YU104690A (sh) Supstituisani imidazo-kondenzovani 6-člani heterocikli kao antagonisti angiotenzina 2
BG101110A (bg) Заместени пиримидинови съединения и тяхното използване
PT1007523E (pt) Derivados indole e 2,3-di-ridroindole, sua preparacao e utilizacao
DE60100506D1 (de) 1,3-dihydro-2h-indol-2-on derivate und deren verwendung als liganden der arginin-vasopressin rezeptoren v1b oder v1b und v1a
BR9711586A (pt) Compostos e uso dos mesmo
TR200200125T2 (tr) Yeni aminotiyazol türevleri, bunların hazırlanması ve bunları içeren farmasötik kompozisyonlar.
ATE202342T1 (de) 5-(4-subst.-piperidinyl-1)-3-aryl-pentansäure derivate als tachykinin rezeptor antagonisten
ES2180573T3 (es) Uso de derivados de indol como antagonistas de 5ht1.
CY1106376T1 (el) Δικυκλικα παραγωγα των αμινο-πυραζινονων, μεθοδος παρασκευης τους και οι φαρμακευτικες συνθεσεις που τα πepιεχουν
DE69725457D1 (de) Piperazinderivate als neurokinin-antagonisten
EA200100517A1 (ru) Антагонисты 5ht1 для антидепрессантной терапии
ATE375985T1 (de) Oxazolylarylpropionsäure derivate und ihre verwendung als ppar agonisten
DE69526668D1 (de) Heterocyclisch substituierte propensäure derivate als nmda antagonisten
BG103502A (en) Heterocyclic derivatives of carboxylic acids, their preparation and application as endothelial receptor antagonists
TR200001080T2 (tr) 2 ile ikame edilmiş 1,2-Benisotiyazol türevleri ve bunların serrotonın antagonistleri

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee